Find residential OCD treatment programs your family can trust.

Residential OCD treatment is an intensive level of care where a person lives at a treatment facility for a period of weeks or months while receiving daily ERP therapy and clinical support. It is typically considered when outpatient therapy has not produced sufficient improvement or when OCD has significantly impaired daily functioning.

Start by searching the OCD RTC directory by state and age group. Look specifically for programs where ERP is the primary treatment modality, not just one of many therapies offered. Call admissions and ask how many hours of ERP a typical resident receives per week. That question alone will tell you a great deal about the program.

Residential OCD treatment typically costs between $15,000 and $50,000 per month depending on the program, location, and level of clinical intensity. Many programs accept private insurance. Some require a single case agreement if the program is out of network. Contact each program’s admissions team directly for current pricing and insurance information.

Many residential OCD programs accept private insurance including Aetna, Cigna, Blue Cross Blue Shield, and UnitedHealthcare. Coverage varies significantly by plan and by program. If a program is out of network, you can request a single case agreement from your insurance provider. Contact the program’s admissions or billing team for insurance verification.

Residential treatment involves living at the facility around the clock and typically provides 20 to 40 hours of therapy per week. A Partial Hospitalization Program (PHP) provides 20 to 30 hours per week while the person lives at home or in a nearby residence. An Intensive Outpatient Program (IOP) provides 9 to 15 hours per week. Residential is the highest intensity and is appropriate when lower levels of care have not been sufficient.

Most acute residential OCD programs run 4 to 12 weeks. Longer-term programs for more complex or severe cases can run 6 to 12 months. Discharge timing should be driven by clinical progress and readiness for a lower level of care, not by arbitrary timelines.